# Comparative Analysis of the Efficacies in Neoadjuvant Chemotherapy of Breast Cancer

> **NCT02613026** · PHASE3 · COMPLETED · sponsor: **307 Hospital of PLA** · enrollment: 104 (actual)

## Conditions studied

- Breast Neoplasms

## Interventions

- **DRUG:** Pirarubicin
- **DRUG:** Docetaxel
- **DRUG:** Cyclophosphamide

## Key facts

- **NCT ID:** NCT02613026
- **Lead sponsor:** 307 Hospital of PLA
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-07
- **Primary completion:** 2013-03
- **Final completion:** 2015-02
- **Target enrollment:** 104 (ACTUAL)
- **Last updated:** 2015-11-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02613026

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02613026, "Comparative Analysis of the Efficacies in Neoadjuvant Chemotherapy of Breast Cancer". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT02613026. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*